Jane Street’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Jane Street’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-42,291	Closed	-$696K	–	10429
2023 Q4	$696K	Buy	+42,291	New	+$666K	﹤0.01%	6212
2023 Q1	–	Sell	-7,564	Closed	-$28.1K	–	10261
2022 Q4	$28.1K	Buy	7,564 +2,969	+65%	+$13.1K	﹤0.01%	8520
2022 Q3	$23K	Buy	+4,595	New	+$25.6K	﹤0.01%	9173
2022 Q1	–	Sell	-8,065	Closed	-$106K	–	11256
2021 Q4	$106K	Buy	8,065 +6,805	+540%	+$113K	﹤0.01%	9225
2021 Q3	$29K	Buy	+1,260	New	+$37.5K	﹤0.01%	9693
2021 Q2	–	Sell	-1,093	Closed	-$79K	–	10613
2021 Q1	$79K	Buy	1,093 +35	+3%	+$2.49K	﹤0.01%	8714
2020 Q4	$46K	Buy	+1,058	New	+$47.4K	﹤0.01%	7326

Jane Street's ORTX Position: Q1 2024 in Review

Jane Street sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 42,291 shares — an estimated $696K sold.

Jane Street first reported a position in ORTX in Q4 2020 and held it in 7 quarters. The position peaked at $696K in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Jane Street reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Jane Street sold 42,291 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $696K.
Jane Street first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2020 and held it in 7 quarters.
Jane Street's Orchard Therapeutics plc American Depositary Shares position peaked at $696K in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.